Ligand Pharmaceuticals

$162.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.08 (+3.88%) Today

$0.00 (0.00%) As of 11:06 AM UTC after-hours

Why Robinhood?

You can buy or sell LGND and other stocks, options, and ETFs commission-free!

About LGND

Ligand Pharmaceuticals Incorporated Common Stock, also called Ligand Pharmaceuticals, is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. The listed name for LGND is Ligand Pharmaceuticals Incorporated Common Stock.

CEO

John L. Higgins

Employees

115

Headquarters

San Diego, California

Founded

1987

Market Cap

2.61B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.16M

High Today

$198.79

Low Today

$153.92

Open Price

$170.00

Volume

5.58M

52 Week High

$198.79

52 Week Low

$57.24

Collections

Analyst Ratings

86%

of 7 ratings

Buy

86%

Hold

14%

Sell

LGND Earnings

$0.00

$0.35

$0.69

$1.04

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 3, Pre-Market